Connect to share and comment

Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suit

(Reuters) - Pfizer Inc said Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd would pay $2.15 billion to settle a patent infringement lawsuit related to its acid-reflux drug Protonix. Japan's Takeda Pharmaceutical Co Ltd, Pfizer's partner on the drug, will receive 36 percent or about $774 million from the settlement.

Pfizer, Takeda settle Protonix patent case with generic drugmakers for $2.15 billion

NEW YORK, N.Y. - Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., one of the world's largest generic drugmakers, will pay $1.6 billion, while India's Sun Pharmaceutical Industries Ltd. will pay $550 million for selling their versions of Protonix before the patent protecting the drug expired. Pfizer Inc., based in New York, said Wednesday that it will receive 64 per cent of the settlement proceeds.

French customs seize 406 kgs of cocaine from Venezuelan boat

French customs officials have seized 406 kilogrammes of cocaine off the French Antilles with a street value of 25 million euros ($33 million), the finance ministry said Wednesday. A raid on May 30 on a sailboat registered in Venezuela led to three arrests, a statement said. The cocaine was hidden in fuel containers. The ketch was intercepted in international waters. The officials said the cocaine, the biggest seizure France has made this year, was destined for Europe.

Alleged cocaine smuggler had drug taped to his legs, border officials say

TORONTO - Canada Border Services Agency says an alleged cocaine smuggler tried to get the drug into the country taped to his legs. Officials say border officers at Toronto's Pearson International Airport referred a traveller for secondary examination. During the course of the examination, the officers noticed the man was "inconsistent" and his belongings were swabbed, producing a positive result for suspected cocaine.

DEA reaches $80M settlement with Walgreens pharmacies over painkiller distribution violations

MIAMI - Federal authorities have reached an $80 million civil settlement with the Walgreens pharmacy chain over rules violations that allowed tens of thousands of units of powerful painkillers such as oxycodone to illegally wind up in the hands of drug addicts and dealers, officials said Tuesday.

Obama reverses course on morning-after pill; critic sees him 'caving to political pressure'

NEW YORK, N.Y. - After setting off a storm of criticism from abortion rights groups, upset that a Democratic president had sided with social conservatives, the Obama administration said it will comply with a judge's order to allow girls of any age to buy emergency contraception without prescriptions. But in doing so at least one opponent of easy access to the contraception thinks the president is buckling to political pressure, rather than making the health of girls a priority.

Obama administration to drop limits on morning-after pill

By Caroline Humer and Jessica Dye NEW YORK (Reuters) - The Obama administration will scrap age restrictions on the sale of emergency contraception pills, making the morning-after pill available to women and girls without a prescription.

US to allow morning-after pill for girls of any age

The Obama administration said Monday it would comply with a judge's order to allow women and girls of any age to purchase emergency contraception, ending its efforts to restrict the drug's availability. The reversal on the politically sensitive issue means that anyone, including young girls, will soon be able to purchase the popular Plan B One-Step morning-after pill over the counter, without a prescription.

Medicare prescribes more brand name drugs than VA

By Genevra Pittman NEW YORK (Reuters Health) - Medicare Part D beneficiaries are two to three times more likely than those covered by the U.S. Department of Veterans Affairs to be prescribed brand name diabetes drugs rather than generics, a new study suggests. Because it doesn't seem the brand name versions work any better, researchers said the extra $1.4 billion Medicare spent on those drugs in 2008 may not have led to improved patient health.

Canada to snuff out medical marijuana production in homes

By Rod Nickel WINNIPEG, Manitoba (Reuters) - Canada, a pioneer in the use of medical marijuana, will take legal production out of private homes next year as it seeks to address more than a decade of neighborhood spats and criminal activity. Health Canada will also snuff out its own production, which has been another legal source of the drug, and leave supplies solely to licensed growers in the private sector.
Syndicate content